![[Avant] Arbre de transmission CV pour 2009-2014 Nissan Maxima 3.5L with Automatic CVT transmission KCV-100110 1990-cadillac-seville Numéro de pièce: KBB-101393 KDA-100498](https://cdn.shopify.com/s/files/1/0642/1105/8866/files/KCV-100110-01_466a16a5-80e9-4b7f-9ed2-f92fcf939171.jpg?v=1771504932)
[Avant] Arbre de transmission CV pour 2009-2014 Nissan Maxima 3.5L with Automatic CVT transmission KCV-100110 1990-cadillac-seville Numéro de pièce: KBB-101393 KDA-100498
EUR125.69EUR147.69
Pay in 4 interest-free payments of $31.42 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 13 - Nov 18
Harbor notes
Description
[Avant] Arbre de transmission CV pour 2009 2014 Nissan Maxima 3.5L with Automatic CVT transmission KCV 100110 1990 cadillac seville Numéro de pièce: KBB 101393 KDA 100498 Numéro de pièce: KBB 101393 65114 BR54136 54426 48880344 748880344 248880344 126276 680344 BD126276 ASR 54426 7973 PF7973M SS7973M FT7973 QE7973M UP7973M D1067 1067 CMF D1067 Produit: Arbre de transmission CV 2011 Nissan Maxima
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
Frequently Asked Questions for [Avant] Arbre de transmission CV pour 2009-2014 Nissan Maxima 3.5L with Automatic CVT transmission KCV-100110 1990-cadillac-seville Numéro de pièce: KBB-101393 KDA-100498
What should I check when reading a translated product listing?
Look for consistency between the final selection and the description you reviewed. Make the decision from verified meaning rather than the most favorable interpretation of translated wording.
How can I make a useful comparison table for several products?
Add relevant limitations alongside the positive features. Save the final comparison with the relevant purchase notes.
How can I check whether a purchase involves ongoing commitments?
Do not infer indefinite access or support from an unspecified term. Do not treat a trial label as a complete explanation of what follows it.